This Article Full Text (OnlineFirst PDF) All Versions of this Article: 1089253208316442v1 12/1/33    most recent Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Google Scholar Articles by Mittnacht, A. J.C. Articles by Konstadt, S. PubMed PubMed Citation Articles by Mittnacht, A. J.C. Articles by Konstadt, S. Social Bookmarking                   What's this?

Anesthetic Considerations in the Patient With Valvular Heart Disease Undergoing Noncardiac Surgery

^* To whom correspondence should be addressed. E-mail: alexander.mittnacht{at}msnyuhealth.org.

	Abstract

Valvular heart disease can be an important finding in patients presenting for noncardiac surgery. Valvular heart disease and resulting comorbidity, such as heart failure or atrial fibrillation, significantly increase the risk for perioperative adverse events. Appropriate preoperative assessment, adequate perioperative monitoring, and early intervention, should hemodynamic disturbances occur, may help prevent adverse events and improve patient outcome. This review article aims to guide the practitioner in the various aspects of anesthetic management in the perioperative care of patients with valvular heart disease. The pharmacological approach to optimization of patient outcome with drugs, such as blockers and lipid-lowering medications (statins), is an evolving field, and recent developments are discussed in this article.

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?